Population Pharmacokinetics of Ciprofloxacin in Neonates and Young Infants Less than Three Months of Age

Ciprofloxacin is used in neonates with suspected or documented Gram-negative serious infections. Currently, its use is off-label partly because of lack of pharmacokinetic studies. Within the FP7 EU project TINN (Treat Infection in NeoNates), our aim was to evaluate the population pharmacokinetics of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Zhao, Wei, Hill, Helen, Le Guellec, Chantal, Neal, Tim, Mahoney, Sarah, Paulus, Stephane, Castellan, Charlotte, Kassai, Behrouz, van den Anker, Johannes N., Kearns, Gregory L., Turner, Mark A., Jacqz-Aigrain, Evelyne
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2014
Schlagworte:
Pharmacology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249352/
https://ncbi.nlm.nih.gov/pubmed/25155587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03568-14
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge